Skip Navigation

Faculty Profiles

Robert Guyton

Robert A. Guyton, MD

Distinguished Charles Ross Hatcher, Jr., Professor of Surgery

Chief, Division of Cardiothoracic Surgery, Department of Surgery, Emory University School of Medicine

Program Director, Three Year Cardiothoracic Surgery Residency, Emory University School of Medicine

Director, Cardiothoracic Research Lab (CTRL), Division of Cardiothoracic Surgery, Emory University School of Medicine

Chief of Cardiothoracic Surgery, Emory University Hospital





American Board of Surgery, American Board of Thoracic Surgery

Year Joined Emory as a Faculty Member



Dr. Guyton has served as chief of the Division of Cardiothoracic Surgery at Emory since 1990. He has held various high-level offices in numerous surgical societies, including a 2003-2004 term as president of the Society of Thoracic Surgeons and an ongoing membership on the Board of Directors of the Thoracic Surgery Foundation for Research and Education. 

Throughout the years, Dr. Guyton has been involved in the creation and refinement of several cardiothoracic surgical techniques. In 1999, he and Dr. Omar Lattouf collaborated on the first implantation in the state of Georgia of an Abiomed biventricular assist system to support a patient suffering from heart failure due to postcardiotomy shock. Beginning in 2007, Dr. Guyton joined Emory CT surgeon scientist Dr. Vinod Thourani and Emory cardiologists Dr. Vasilis Babaliaros and Dr. Peter Block as one of the local surgical co-PIS  of the multi-center PARTNER I trial of transcatheter aortic valve replacement (TAVR). The results of the national trial influenced FDA approval of the SAPIEN transfemoral transcatheter heart valve for treatment of high-risk patients with aortic stenosis in 2011.

In 2014, Dr. Guyton was inducted into Emory's Millipub Club for being co-author of a paper that has been cited more than 1,000 times in the literature. The paper was "Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery," published in the October 2010 edition of New England Journal of Medicine, and it reported the results of comparing TAVR to such standard therapies as balloon aortic valvuloplasty. Dr. Guyton and his co-authors concluded that the reduced mortality among patients treated with TAVR as opposed to traditional methods was significant.


View Dr. Guytons's publications in PubMed.


Medical School

Postgraduate Training

Honors and Awards

Current Organizational Memberships

Editorial Boards

Clinical and Research Interests

««return to top